Loading
Total declarations
Company
▲ Purchases (8 ops.)
▼ Sales (1 ops.)
Latest filing published 20 Oct 2025 for BioRestorative Therapies, Inc., €16k. Read the official filing
Filing timeline
BuySaleFrancisco Silva
Insider track record
Disclosed buys
8
Disclosed sells
1
T+90 hit rate
43%
T+90 mean return
+0.4%
Across 7 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Francisco Silva: trading record in brief
Francisco Silva (senior executive) discloses dealings in BioRestorative Therapies, Inc. to SEC (Form 4). Over a trading history stretching from 16 November 2021 to 6 October 2025, the count stands at 16 filings.
The open-market side counts 8 purchases for €67k alongside 1 sale for €13k. The net balance comes to €54k on the buying side. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Outside the open market, there are 7 share grants.
Half of the purchases are above €2,798 and half below. Of 8 purchases, 5 formed part of a group of insiders buying within 30 days of each other. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase.
The newest entry dates from 20 October 2025: a share grant of €16k, in BioRestorative Therapies, Inc. The last insider purchase was made public on 10 April 2024, 921 days ago. The median gap between a trade and its publication by SEC (Form 4) is 3 days. US insiders must file a Form 4 within two business days of a trade. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Francisco Silva
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations16 total
11,719 shares@ US$1.6011.3% of flowComon StockSEC:0001021771-25-000141:0
476 shares@ US$1.130.3% of flowCommon StockSEC:0001021771-24-000091:0
Canonical exit: 7 Jul 2024 (T+90)
17,193 shares@ US$1.3912.8% of flowCommon StockSEC:0001021771-24-000079:0
4,954 shares@ US$2.225.9% of flowCommon StockSEC:0001021771-23-000086:0
Canonical exit: 29 Nov 2023 (T+90)
747 shares@ US$3.561.4% of flowCommon StockSEC:0001021771-23-000034:0
Canonical exit: 29 Jun 2023 (T+90)
6,729 shares@ US$2.9210.7% of flowCommon StockSEC:0001021771-23-000028:0
374 shares@ US$2.990.6% of flowCommon StockSEC:0001567619-23-003891:0
943 shares@ US$2.61621.4% of flowCommon StockSEC:0001567619-22-020707:0
Canonical exit: 19 Feb 2023 (T+90)
725 shares@ US$3.38841.5% of flowCommon StockSEC:0001567619-22-018437:0
Canonical exit: 10 Jan 2023 (T+90)
806 shares@ US$3.68861.8% of flowCommon StockSEC:0001567619-22-018424:0
Canonical exit: 9 Jan 2023 (T+90)
3,958 shares@ US$3.3887.8% of flowCommon StockSEC:0001567619-22-017246:0
263 shares@ US$3.77740.7% of flowCommon StockSEC:0001567619-22-012893:0
565 shares@ US$4.64931.7% of flowCommon StockSEC:0001567619-22-012496:0
12,438 sharesCommon StockSEC:0001567619-22-007349:0
4,000 shares@ US$6.656516.5% of flowCommon StockSEC:0001567619-21-020924:0
Canonical exit: 17 Feb 2022 (T+90)
3,826 shares@ US$6.8316.2% of flowCommon StockSEC:0001567619-21-020585:0
Canonical exit: 14 Feb 2022 (T+90)
16 of 16 declarations
